[SYRS] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
05-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -58.07%
YoY- -30.79%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 5,467 7,802 5,697 5,162 4,827 5,699 3,828 26.84%
PBT -25,146 -23,813 -26,027 -22,490 -14,228 -30,130 -19,486 18.54%
Tax -1,507 986 984 969 967 1,417 0 -
NP -23,639 -23,813 -26,027 -22,490 -14,228 -30,130 -19,486 13.75%
Tax Rate - - - - - - - -
Total Cost 29,106 31,615 31,724 27,652 19,055 35,829 23,314 15.95%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -432.39 -305.22 -456.85 -435.68 -294.76 -528.69 -509.04 -10.31%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -3.75 -3.78 -4.14 -3.60 -2.32 -4.91 -4.26 -8.15%
EPS Diluted -3.75 -3.78 -4.14 -3.58 -2.32 -4.91 -4.26 -8.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.